PICO Advisory Sub Committee – Applications considered
- 1643 – Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer Disease
- 1649 – Modification of the wording of minimally invasive glaucoma surgery existing item number to encompass the use of a microcatheter
- 1651 – Integrated, closed-system extracorporeal photopheresis with ultraviolet-A irradiation in conjunction with a photoactive drug, methoxsalen, for the treatment of chronic graft-versus-host disease after haematopoietic stem cell transplantation in adults